AARTI DRUGS Fact Sheet, AARTI DRUGS Financial Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

AARTI DRUGS Fact Sheet    (ADRG)


Watch: Predict Stock's Next Move Using Volumes


Here is the latest financial fact sheet of AARTI DRUGS. For more details, see the AARTI DRUGS quarterly results and AARTI DRUGS share price and chart. For a sector overview, read our pharmaceuticals sector report.

AARTI DRUGS Price History

Price Rs 716.6
Mkt Cap Rs m 66,787
Vol '000 31.2
P/E X 23.8
P/CF X 35.1
EPS (TTM) Rs 30.1
% ch % -0.9
No. of shares m 93.20
% ch week % -0.1
% ch 1-mth % 0.1
% ch 12-mth % 95.2
52 week H/L Rs 1,025.0/360.4
(As on Jul 23, 2021 (Close))
* Results Consolidated
Excel EXPORT | DO YOU LIKE THESE FACTSHEETS? TELL US!

AARTI DRUGS Financials

No. of Mths
Year Ending
12
Mar-16
*
12
Mar-17
*
12
Mar-18
*
12
Mar-19
*
12
Mar-20
*
5-Yr Chart
Click to enlarge
AARTI DRUGS EQUITY SHARE DATA
High Rs874684785705813 
Low Rs443431456500419 
Sales per share (Unadj.) Rs432.0462.0519.4662.0775.1 
Earnings per share (Unadj.) Rs28.434.334.938.160.7 
Diluted earnings per shareRs7.48.88.89.615.2 
Cash flow per share (Unadj.) Rs43.550.451.956.181.6 
Dividends per share (Unadj.) Rs6.751.001.001.002.00 
Adj. dividends per shareRs1.750.260.250.250.50 
Dividend yield (eoy) %1.00.20.20.20.3 
Book value per share (Unadj.) Rs147.6167.7193.1230.5280.0 
Adj. book value per shareRs38.342.948.958.370.0 
Shares outstanding (eoy) m24.2223.8623.5823.5823.30 
Bonus / Rights / Conversions  ----- 
Price / Sales ratio x1.51.21.20.90.8 
Avg P/E ratio x23.216.317.815.810.2 
P/CF ratio (eoy) x15.211.112.010.77.5 
Price / Book Value ratio x4.53.33.22.62.2 
Dividend payout %23.82.92.92.63.3 
Avg Mkt Cap Rs m15,94713,30214,63314,20814,352 
No. of employees `000NANANANANA 
Total wages/salary Rs m402480521546613 
Avg. sales/employee Rs ThNMNMNMNMNM 
Avg. wages/employee Rs ThNMNMNMNMNM 
Avg. net profit/employee Rs ThNMNMNMNMNM 
AARTI DRUGS INCOME DATA
Net Sales Rs m10,46411,02312,24715,60918,061 
Other income Rs m040102415 
Total revenues Rs m10,46411,06312,25715,63418,076 
Gross profit Rs m1,7981,9052,0192,1472,700 
Depreciation Rs m365385401426488 
Interest Rs m480400384435374 
Profit before tax Rs m9531,1601,2451,3101,853 
Minority Interest Rs m00000 
Prior Period Items Rs m00000 
Extraordinary Inc (Exp) Rs m00000 
Tax Rs m266342422413439 
Profit after tax Rs m6878188238981,414 
Gross profit margin %17.217.316.513.814.9 
Effective tax rate %27.929.533.931.523.7 
Net profit margin %6.67.46.75.77.8 
AARTI DRUGS BALANCE SHEET DATA
Current assets Rs m5,6525,7147,3697,8439,040 
Current liabilities Rs m5,0104,9436,2175,9106,247 
Net working cap to sales %6.17.09.412.415.5 
Current ratio x1.11.21.21.31.4 
Inventory Days Days38633 
Debtors Days Days1169811210799 
Net fixed assets Rs m5,3706,1966,5256,7126,725 
Share capital Rs m242239236236233 
"Free" reserves Rs m3,3323,7634,3185,1996,292 
Net worth Rs m3,5744,0014,5545,4346,525 
Long term debt Rs m1,9122,0152,0272,0821,803 
Total assets Rs m11,02211,91013,89414,55515,765 
Interest coverage x3.03.94.24.06.0 
Debt to equity ratio x0.50.50.40.40.3 
Sales to assets ratio x0.90.90.91.11.1 
Return on assets %10.610.28.79.211.3 
Return on equity %19.220.418.116.521.7 
Return on capital %26.125.924.723.226.7 
Exports to sales %34.335.631.132.228.3 
Imports to sales %42.438.034.133.335.0 
Exports (fob) Rs m3,5853,9203,8075,0225,106 
Imports (cif) Rs m4,4324,1844,1785,2046,323 
Fx inflow Rs m3,5853,9203,8075,0225,106 
Fx outflow Rs m4,5744,2984,2875,3886,501 
Net fx Rs m-989-378-480-366-1,395 
AARTI DRUGS CASH FLOW
From Operations Rs m 1,333 1,748 698 1,431 2,507 
From Investments Rs m -988 -1,070 -735 -617 -332 
From Financial Activity Rs m -333 -682 39 -801 -2,154 
Net Cashflow Rs m 12 -5 1 14 21 
* Results Consolidated
Source: Accord Fintech, Equitymaster

Share Holding

Indian Promoters 60.1%
Foreign collaborators 0.0%
Indian inst/Mut Fund 4.6%
FIIs 2.6%
ADR/GDR 0.0%
Free float 39.9%
Shareholders 177,993
Pledged promoter(s) holding 0.0%
 

Company Information

REGD OFF Plot No N 198, M I D C, Tarapur Village - Patembhi Taluka Palghar, Thane - 401506
E-MAIL NA WEB www.aartidrugs.com
TEL FAX
SECTOR PHARMACEUTICALS GROUP Aarti
TR AGENT Link Intime India Pvt Ltd., C 101 247 Park, LBS Marg, Vikhroli (West)
YEAR OF INC: 1984 BSE CODE: 524348 FV (Rs): 10 DIV YIELD (%): 0.1

More Pharmaceuticals Company Fact Sheets:   SANJIVANI PA  PARENT.DRUGS  JUBILANT PHARMOVA   SWAGRUHA INFRA  ORTIN LABS   

Compare AARTI DRUGS With:   SANJIVANI PA  PARENT.DRUGS  JUBILANT PHARMOVA   SWAGRUHA INFRA  ORTIN LABS   




Today's Market

Sensex Ends 139 Points Higher; ICICI Bank, Wipro and ITC Among Top Nifty Gainers(Closing)

Indian share markets witnessed positive trading activity throughout the day today and ended higher.

Views on news

AARTI DRUGS Announces Quarterly Results (4QFY21); Net Profit Down 12.2% (Quarterly Result Update)

Jul 8, 2021 | Updated on Jul 8, 2021

For the quarter ended March 2021, AARTI DRUGS has posted a net profit of Rs 516 m (down 12.2% YoY). Sales on the other hand came in at Rs 5 bn (up 11.6% YoY). Read on for a complete analysis of AARTI DRUGS's quarterly results.

Why Did Pharma Stocks Surge? (Views On News)

Jul 17, 2021

A look into the factors contributing to the rally in pharma stocks.

Bajaj Healthcare Rallies 11% on DRDO Nod to Manufacture Oral Covid Drug (Views On News)

Jul 8, 2021

Bajaj Healthcare has more than doubled investors' wealth in the year 2021 so far. The counter has delivered over 240% return in the last one year.

Aurobindo Pharma Rallies on Sale of Injectables Unit to Subsidiary (Views On News)

Jul 2, 2021

Here's why the company sold its business unit to Eugia Pharma Specialities.

KIMS Shares Make Strong Debut Listing at a 22% Premium (Views On News)

Jun 28, 2021

KIMS shares pare gains after making a strong debut on the exchanges.

More Views on News

Most Popular

A 25 Bagger Indian Stock at the Centre of the Global Semiconductor Chip Shortage (Profit Hunter)

Jul 13, 2021

One technology company in India is grossly underrated despite its dominant role in semiconductor chip designing.

RBI Opens a New Market for Investors (Fast Profits Daily)

Jul 16, 2021

You now have a new way to create wealth. Grab it with both hands.

OPEC is Dying! RIP OPEC (Fast Profits Daily)

Jul 13, 2021

Why the global oil cartel is unravelling and how India stands to gain.

A Better Way than the Zomato IPO to Play the Food Delivery Megatrend (Profit Hunter)

Jul 14, 2021

A unique backdoor way of making big profits from smallcap companies.

Top 3 Risks for the Nifty Today (Fast Profits Daily)

Jul 12, 2021

Don't ignore the risks to the Nifty that are hiding in plain sight.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2021
Get our special report Multibagger Stocks Guide (2021 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

TRACK AARTI DRUGS

  • Track your investment in AARTI DRUGS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON AARTI DRUGS

AARTI DRUGS - MYLAN COMPARISON

COMPARE AARTI DRUGS WITH

MARKET STATS